|
Stanley N. Lapidus, President and CEO of Helicos BioSciences Corporation, presides over the closing bell. |
| |
Stanley N. Lapidus, President and CEO of Helicos BioSciences Corporation, presides over the closing bell. |
Stanley N. Lapidus, President and CEO of Helicos BioSciences Corporation, presides over the closing bell.
Monday July 2, 2007
from Nasdaq MarketSite
in New York's Times Square
Helicos BioSciences Corporation
[HLCS] |
| |
Additional Photographs & Reprint Permissions
Archived MarketSite Events | Summary Quote
Stanley N. Lapidus, President and CEO of Helicos BioSciences Corporation (HLCS), presides over the closing bell.
Helicos BioSciences Corporation is a life sciences company developing innovative genetic analysis technologies for the research, drug discovery and clinical diagnostics markets. The company has developed its proprietary True Single Molecule Sequencing technology to enable ultra-high-throughput genetic analysis based on the direct sequencing of single molecules of nucleic acids. The company's corporate headquarters are located at One Kendall Square, Building 700, Cambridge, MA 02139, and its telephone number is (617) 264-1800.
Reprints
Click for larger pictures of the NASDAQ MarketSite.
Additional Photographs for 07/02/2007
© Copyright 2007, The NASDAQ Stock Market, Inc.
Reprinted with the permission of The Nasdaq Stock Market, Inc. |
|
